Individuals with Asthma: There is a risk that glutathione could exacerbate asthma symptoms
Rather than viewing depression, fatigue, insomnia, irritability, cognitive decline and PTSD-like symptoms only as psychiatric problems, the protocol evaluates neuro-inflammation, hypothalamic-pituitary dysfunction, hormone deficiencies, neurosteroids, metabolic health and inflammatory signaling that may be impairing recovery
is supported by the Japan Society for the Promotion of Science (grant-in-aid for scientific research), the Ministry of Health, Labour and Welfare, Japan (Research on Rare and Intractable Diseases), and the Japan Agency for Medical Research Development (AMED) (the Practical Research Project for Rare/Intractable Diseases, Initiative on Rare and Intractable Diseases, and Program for an Integrated Database of Clinical and Genomic Information)
ALA IV therapy has also demonstrated promising effects in individuals suffering from diabetic neuropathy